Report Detail
Global Cytotoxic Drug Market Growth 2019-2024
- RnM3064712 |
- 06 March, 2019 |
- Global |
- 166 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic’ and ‘cytotoxic’ are often used interchangeably.
The classification of Cytotoxic Drug includes Injection, Solid Oral Dose Forms and others, and the proportion of Injection in 2016 is about 94%, and the proportion is in decreasing trend from 2012 to 2016.
Cytotoxic Drug is widely used in Breast Cancer, Blood Cancer, Prostate Cancer, Respiratory/Lung Cancer and other diseases. The most proportion of Cytotoxic Drug is for other diseases, and the consumption proportion for blood cancer in 2016 is about 24%.
Market competition is intense. Roche, Eli Lilly, Celgene, Sanofi, eisai, Sumitomo Dainippon Pharma, Merck, Seattle Genetics, Takeda, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Cytotoxic Drug market will register a 1.1% CAGR in terms of revenue, the global market size will reach US$ 14900 million by 2024, from US$ 13900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cytotoxic Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cytotoxic Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Cytotoxic Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Injection
Solid Oral Dose Forms
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cytotoxic Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cytotoxic Drug market by identifying its various subsegments.
Focuses on the key global Cytotoxic Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cytotoxic Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cytotoxic Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Cytotoxic Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cytotoxic Drug Consumption 2014-2024
- 2.1.2 Cytotoxic Drug Consumption CAGR by Region
- 2.2 Cytotoxic Drug Segment by Type
- 2.2.1 Injection
- 2.2.2 Solid Oral Dose Forms
- 2.2.3 Others
- 2.3 Cytotoxic Drug Consumption by Type
- 2.3.1 Global Cytotoxic Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Cytotoxic Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Cytotoxic Drug Sale Price by Type (2014-2019)
- 2.4 Cytotoxic Drug Segment by Application
- 2.4.1 Breast Cancer
- 2.4.2 Blood Cancer
- 2.4.3 Prostate Cancer
- 2.4.4 Respiratory/Lung Cancer
- 2.4.5 Other
- 2.5 Cytotoxic Drug Consumption by Application
- 2.5.1 Global Cytotoxic Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Cytotoxic Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Cytotoxic Drug Sale Price by Application (2014-2019)
3 Global Cytotoxic Drug by Players
- 3.1 Global Cytotoxic Drug Sales Market Share by Players
- 3.1.1 Global Cytotoxic Drug Sales by Players (2017-2019)
- 3.1.2 Global Cytotoxic Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Cytotoxic Drug Revenue Market Share by Players
- 3.2.1 Global Cytotoxic Drug Revenue by Players (2017-2019)
- 3.2.2 Global Cytotoxic Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Cytotoxic Drug Sale Price by Players
- 3.4 Global Cytotoxic Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Cytotoxic Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Cytotoxic Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Cytotoxic Drug by Regions
- 4.1 Cytotoxic Drug by Regions
- 4.1.1 Global Cytotoxic Drug Consumption by Regions
- 4.1.2 Global Cytotoxic Drug Value by Regions
- 4.2 Americas Cytotoxic Drug Consumption Growth
- 4.3 APAC Cytotoxic Drug Consumption Growth
- 4.4 Europe Cytotoxic Drug Consumption Growth
- 4.5 Middle East & Africa Cytotoxic Drug Consumption Growth
5 Americas
- 5.1 Americas Cytotoxic Drug Consumption by Countries
- 5.1.1 Americas Cytotoxic Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Cytotoxic Drug Value by Countries (2014-2019)
- 5.2 Americas Cytotoxic Drug Consumption by Type
- 5.3 Americas Cytotoxic Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Cytotoxic Drug Consumption by Countries
- 6.1.1 APAC Cytotoxic Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Cytotoxic Drug Value by Countries (2014-2019)
- 6.2 APAC Cytotoxic Drug Consumption by Type
- 6.3 APAC Cytotoxic Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Cytotoxic Drug by Countries
- 7.1.1 Europe Cytotoxic Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Cytotoxic Drug Value by Countries (2014-2019)
- 7.2 Europe Cytotoxic Drug Consumption by Type
- 7.3 Europe Cytotoxic Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Cytotoxic Drug by Countries
- 8.1.1 Middle East & Africa Cytotoxic Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Cytotoxic Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Cytotoxic Drug Consumption by Type
- 8.3 Middle East & Africa Cytotoxic Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Cytotoxic Drug Distributors
- 10.3 Cytotoxic Drug Customer
11 Global Cytotoxic Drug Market Forecast
- 11.1 Global Cytotoxic Drug Consumption Forecast (2019-2024)
- 11.2 Global Cytotoxic Drug Forecast by Regions
- 11.2.1 Global Cytotoxic Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Cytotoxic Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Cytotoxic Drug Forecast by Type
- 11.8 Global Cytotoxic Drug Forecast by Application
12 Key Players Analysis
- 12.1 Roche
- 12.1.1 Company Details
- 12.1.2 Cytotoxic Drug Product Offered
- 12.1.3 Roche Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Roche News
- 12.2 Eli Lilly
- 12.2.1 Company Details
- 12.2.2 Cytotoxic Drug Product Offered
- 12.2.3 Eli Lilly Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Eli Lilly News
- 12.3 Celgene
- 12.3.1 Company Details
- 12.3.2 Cytotoxic Drug Product Offered
- 12.3.3 Celgene Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Celgene News
- 12.4 Sanofi
- 12.4.1 Company Details
- 12.4.2 Cytotoxic Drug Product Offered
- 12.4.3 Sanofi Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sanofi News
- 12.5 eisai
- 12.5.1 Company Details
- 12.5.2 Cytotoxic Drug Product Offered
- 12.5.3 eisai Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 eisai News
- 12.6 Sumitomo Dainippon Pharma
- 12.6.1 Company Details
- 12.6.2 Cytotoxic Drug Product Offered
- 12.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Sumitomo Dainippon Pharma News
- 12.7 Merck
- 12.7.1 Company Details
- 12.7.2 Cytotoxic Drug Product Offered
- 12.7.3 Merck Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Merck News
- 12.8 Seattle Genetics
- 12.8.1 Company Details
- 12.8.2 Cytotoxic Drug Product Offered
- 12.8.3 Seattle Genetics Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Seattle Genetics News
- 12.9 Takeda
- 12.9.1 Company Details
- 12.9.2 Cytotoxic Drug Product Offered
- 12.9.3 Takeda Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Takeda News
- 12.10 Haosoh Pharma
- 12.10.1 Company Details
- 12.10.2 Cytotoxic Drug Product Offered
- 12.10.3 Haosoh Pharma Cytotoxic Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Haosoh Pharma News
- 12.11 Novartis
- 12.12 AstraZeneca
- 12.13 Jazz Pharma
- 12.14 Spectrum Pharma
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cytotoxic Drug . Industry analysis & Market Report on Cytotoxic Drug is a syndicated market report, published as Global Cytotoxic Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Cytotoxic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
